Effectiveness of theory-based WhatsApp chatbot outreach in colorectal cancer screening uptake: a randomized controlled trial
In brief
WhatsApp chatbot lifts colorectal screening to 36% vs 28% with simple text
In a randomized trial of 500 adults aged 50-75, a theory-based WhatsApp chatbot delivering video education and personalized risk feedback raised screening uptake to 36% at three months, compared with 27.6% after a single text reminder. The benefit persisted to six months, though early uptake at one month was similar, suggesting interactive messaging may improve longer-term participation.
- Journal
- Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association (Q1)
- Published
- 19 August 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Thomas Yuen Tung Lam, Zebulon To, Zixin Johnson Wang, Phoenix Kit Han Mo, Wai Man Lau, Yueyang Yi, et al.
- PMID
- 42617827
- DOI
- 10.1016/j.cgh.2026.08.006
Why clinicians should know about it
- Picked for Gastroenterology (top studies of the week, 23 August 2026): WhatsApp chatbot improves colorectal cancer screening uptake RCT
Abstract
BACKGROUND & AIMS: Colorectal cancer (CRC) screening effectively reduces both the incidence and mortality associated with CRC. However, despite the growing implementation of organized screening programs, uptake rates remain suboptimal worldwide. We aim to evaluate the effectiveness of a novel, theory-based WhatsApp chatbot outreach (WCO) intervention in improving the CRC screening uptake rate compared to a standard text reminder (STR). METHODS: We conducted a prospective, open-label, two-arm, parallel, randomized controlled trial in a community setting. Asymptomatic individuals aged 50-75 with access to WhatsApp Messenger were recruited and randomized to WCO or STR group in a 1:1 basis. The WCO delivered a health education video, and a personalized risk assessment tailored to participants' stages of change based on the Transtheoretical Model (TTM). Additionally, it provided practical information on where and how to access screening services. The STR was a single text reminder with the organized screening program website link. Primary outcome was CRC screening uptake rate were assessed at 3-month. Secondary outcomes were 1-and 6-month uptake rates. RESULTS: From July to October 2024, 500 participants were recruited and randomized. Their baseline characteristics were similar between groups. The CRC screening uptake rate was significantly higher in the WCO group than in the STR group at 3-month (36% vs 27.6%, p=0.043). This difference remained at 6-month (45.6% vs 36.4%, p=0.045), while the uptake rate was similar between groups at 1-month. CONCLUSIONS: The WCO intervention improved CRC screening uptake at 3 months, with supportive findings at 6-months.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.